Nifty
Sensex
:
:
17698.15
59462.78
39.15 (0.22%)
130.18 (0.22%)

Pharmaceuticals & Drugs - API

Rating :
53/99

BSE: 532488 | NSE: DIVISLAB

3726.20
12-Aug-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 3950.05
  • 3958.20
  • 3700.00
  • 3948.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2107936
  •  79651.24
  •  5425.10
  •  3365.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 98,972.00
  • 33.43
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 96,153.12
  • 0.80%
  • 8.44

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.94%
  • 1.35%
  • 9.53%
  • FII
  • DII
  • Others
  • 16.52%
  • 19.43%
  • 1.23%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.37
  • 18.15
  • 18.43

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.88
  • 25.18
  • 16.31

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.27
  • 27.55
  • 29.08

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 33.49
  • 44.45
  • 49.26

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.82
  • 8.43
  • 10.10

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 25.44
  • 28.93
  • 32.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
2,254.52
1,960.64
14.99%
2,518.44
1,788.19
40.84%
2,493.24
1,701.44
46.54%
1,987.51
1,749.30
13.62%
Expenses
1,407.82
1,108.59
26.99%
1,414.02
1,071.93
31.91%
1,396.06
1,010.23
38.19%
1,169.44
1,008.16
16.00%
EBITDA
846.70
852.05
-0.63%
1,104.42
716.26
54.19%
1,097.18
691.21
58.73%
818.07
741.14
10.38%
EBIDTM
37.56%
43.46%
43.85%
40.05%
44.01%
40.63%
41.16%
42.37%
Other Income
88.39
35.97
145.73%
52.39
23.52
122.75%
16.62
19.32
-13.98%
19.11
13.64
40.10%
Interest
0.13
0.28
-53.57%
0.08
0.21
-61.90%
0.23
0.27
-14.81%
0.21
0.16
31.25%
Depreciation
83.66
73.26
14.20%
80.99
70.08
15.57%
79.91
68.18
17.20%
77.35
61.13
26.53%
PBT
851.30
814.48
4.52%
1,075.74
669.49
60.68%
1,033.66
642.08
60.99%
759.62
693.49
9.54%
Tax
149.29
257.37
-41.99%
181.10
167.47
8.14%
131.42
171.46
-23.35%
153.16
173.90
-11.93%
PAT
702.01
557.11
26.01%
894.64
502.02
78.21%
902.24
470.62
91.71%
606.46
519.59
16.72%
PATM
31.14%
28.41%
35.52%
28.07%
36.19%
27.66%
30.51%
29.70%
EPS
26.45
20.99
26.01%
33.70
18.91
78.21%
33.99
17.73
91.71%
22.85
19.57
16.76%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
9,253.71
8,959.83
6,969.40
5,394.42
4,946.26
3,891.49
4,064.34
3,776.36
3,114.94
2,532.14
2,144.84
Net Sales Growth
28.53%
28.56%
29.20%
9.06%
27.10%
-4.25%
7.63%
21.23%
23.02%
18.06%
 
Cost Of Goods Sold
3,136.96
2,967.14
2,324.08
2,108.54
1,825.22
1,534.06
1,534.00
1,505.32
1,213.24
914.15
798.63
Gross Profit
6,116.75
5,992.69
4,645.32
3,285.88
3,121.04
2,357.43
2,530.34
2,271.04
1,901.70
1,617.99
1,346.21
GP Margin
66.10%
66.88%
66.65%
60.91%
63.10%
60.58%
62.26%
60.14%
61.05%
63.90%
62.77%
Total Expenditure
5,387.34
5,078.72
4,108.34
3,571.21
3,073.24
2,628.74
2,617.20
2,358.04
1,948.69
1,516.76
1,328.87
Power & Fuel Cost
-
392.33
319.15
280.73
248.78
228.73
198.80
180.34
170.82
147.40
131.02
% Of Sales
-
4.38%
4.58%
5.20%
5.03%
5.88%
4.89%
4.78%
5.48%
5.82%
6.11%
Employee Cost
-
946.16
825.76
621.05
542.27
456.06
499.90
361.19
290.42
232.46
197.72
% Of Sales
-
10.56%
11.85%
11.51%
10.96%
11.72%
12.30%
9.56%
9.32%
9.18%
9.22%
Manufacturing Exp.
-
365.92
297.84
258.91
212.96
182.67
169.15
169.42
147.24
121.10
104.85
% Of Sales
-
4.08%
4.27%
4.80%
4.31%
4.69%
4.16%
4.49%
4.73%
4.78%
4.89%
General & Admin Exp.
-
236.44
175.26
148.62
105.30
139.33
88.22
73.91
63.85
51.74
44.15
% Of Sales
-
2.64%
2.51%
2.76%
2.13%
3.58%
2.17%
1.96%
2.05%
2.04%
2.06%
Selling & Distn. Exp.
-
127.01
124.03
85.36
73.08
64.02
67.48
56.04
51.93
44.22
51.29
% Of Sales
-
1.42%
1.78%
1.58%
1.48%
1.65%
1.66%
1.48%
1.67%
1.75%
2.39%
Miscellaneous Exp.
-
43.72
42.22
68.00
65.63
23.87
59.65
11.80
11.18
5.69
51.29
% Of Sales
-
0.49%
0.61%
1.26%
1.33%
0.61%
1.47%
0.31%
0.36%
0.22%
0.06%
EBITDA
3,866.37
3,881.11
2,861.06
1,823.21
1,873.02
1,262.75
1,447.14
1,418.32
1,166.25
1,015.38
815.97
EBITDA Margin
41.78%
43.32%
41.05%
33.80%
37.87%
32.45%
35.61%
37.56%
37.44%
40.10%
38.04%
Other Income
176.51
115.90
62.67
189.63
155.63
113.44
74.89
97.44
44.70
70.60
44.81
Interest
0.65
2.00
2.10
7.14
4.68
2.37
3.36
4.74
2.88
2.96
2.59
Depreciation
321.91
311.51
255.59
186.24
168.90
142.49
123.33
118.18
136.00
92.12
76.95
PBT
3,720.32
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
Tax
614.97
723.05
681.75
442.92
502.33
354.32
334.92
267.06
220.56
217.58
179.23
Tax Rate
16.53%
19.63%
25.57%
24.34%
27.08%
28.78%
24.00%
19.17%
20.57%
21.96%
22.94%
PAT
3,105.35
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
PAT before Minority Interest
3,105.35
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
33.56%
33.04%
28.47%
25.52%
27.35%
22.54%
26.09%
29.81%
27.34%
30.54%
28.07%
PAT Growth
51.53%
49.19%
44.15%
1.76%
54.24%
-17.30%
-5.81%
32.21%
10.11%
28.46%
 
EPS
116.96
111.50
74.74
51.85
50.95
33.03
39.94
42.40
32.07
29.13
22.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
11,728.18
9,294.61
7,309.92
6,957.15
5,924.80
5,357.39
4,293.31
3,495.36
2,963.35
2,500.60
Share Capital
53.09
53.09
53.09
53.09
53.09
53.09
53.09
26.55
26.55
26.55
Total Reserves
11,675.09
9,241.52
7,256.83
6,904.06
5,871.71
5,304.30
4,240.21
3,468.81
2,936.80
2,474.05
Non-Current Liabilities
436.51
363.94
294.57
991.38
1,768.91
1,411.75
85.17
841.57
650.05
469.75
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.47
1.05
1.55
2.10
Long Term Provisions
26.71
25.42
20.52
772.54
1,577.26
1,288.92
11.57
714.30
533.49
388.43
Current Liabilities
2,454.44
1,728.35
1,820.53
846.75
653.42
659.45
519.50
775.53
627.41
554.45
Trade Payables
795.70
763.20
590.72
492.26
411.21
445.80
232.69
226.87
151.70
160.44
Other Current Liabilities
394.02
340.42
290.09
243.59
175.46
176.63
240.58
203.45
147.80
130.08
Short Term Borrowings
0.00
0.35
33.63
105.60
63.11
35.74
41.42
25.07
16.32
30.51
Short Term Provisions
1,264.72
624.38
906.09
5.30
3.64
1.28
4.81
320.14
311.58
233.42
Total Liabilities
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.98
5,112.46
4,240.81
3,524.80
Net Block
4,325.05
3,703.87
2,781.85
2,087.77
1,996.19
1,559.19
1,438.77
1,308.89
1,221.84
908.72
Gross Block
5,624.27
4,691.86
3,514.25
2,633.93
2,373.45
1,793.95
2,196.08
1,953.02
1,740.34
1,338.35
Accumulated Depreciation
1,299.22
987.99
732.40
546.16
377.26
234.76
757.32
644.13
518.50
429.63
Non Current Assets
5,008.74
4,596.30
3,851.49
4,145.23
3,812.01
3,418.08
1,870.93
2,340.06
1,984.45
1,660.69
Capital Work in Progress
469.93
710.62
919.69
491.91
119.76
443.57
263.91
218.18
144.48
303.41
Non Current Investment
72.01
0.01
0.01
547.26
0.01
0.01
0.01
0.00
0.00
0.00
Long Term Loans & Adv.
133.70
172.59
144.50
1,012.93
1,688.23
1,406.48
162.44
812.63
618.03
448.49
Other Non Current Assets
8.05
9.21
5.44
5.36
7.82
8.83
5.80
0.35
0.09
0.07
Current Assets
9,610.39
6,790.60
5,573.53
4,650.05
4,535.12
4,010.51
3,027.04
2,772.40
2,256.35
1,864.11
Current Investments
0.00
0.00
971.35
1,398.34
1,889.28
1,630.72
802.85
733.00
501.88
407.81
Inventories
2,828.62
2,145.23
1,863.86
1,772.34
1,350.67
1,319.91
1,207.83
1,162.64
932.42
835.69
Sundry Debtors
2,423.88
1,676.52
1,413.35
1,163.37
1,014.36
900.92
880.92
741.64
723.70
512.00
Cash & Bank
2,818.88
2,156.03
122.63
115.26
112.46
78.70
73.43
65.22
40.51
40.89
Other Current Assets
1,539.01
51.95
52.16
142.20
168.35
80.26
62.01
69.89
57.85
67.71
Short Term Loans & Adv.
1,509.32
760.87
1,150.18
58.54
43.37
59.59
42.88
54.98
48.16
57.97
Net Current Assets
7,155.95
5,062.25
3,753.00
3,803.30
3,881.70
3,351.06
2,507.54
1,996.87
1,628.95
1,309.66
Total Assets
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.97
5,112.46
4,240.80
3,524.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
1,911.80
1,946.93
1,215.94
954.30
775.86
1,150.37
1,037.86
826.33
556.75
479.97
PBT
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
Adjustment
239.73
189.29
60.01
83.51
32.19
93.87
60.94
91.24
77.55
59.25
Changes in Working Capital
-1,370.45
-264.08
-218.30
-499.84
-219.11
-37.14
-155.03
-125.55
-298.39
-186.05
Cash after chg. in Working capital
2,552.78
2,591.25
1,661.17
1,438.74
1,044.41
1,452.07
1,298.75
1,037.76
770.07
654.44
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-640.98
-644.32
-445.23
-484.44
-268.55
-301.70
-260.89
-211.43
-213.32
-174.47
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2,194.92
75.13
-83.47
-685.40
-478.30
-1,139.60
-406.41
-520.84
-305.15
-254.54
Net Fixed Assets
-691.54
-968.33
-1,302.55
-632.52
-255.54
222.19
-288.75
-286.31
-242.98
-368.08
Net Investments
-72.00
971.35
974.24
-56.30
-257.57
-826.05
-77.22
-231.12
-94.07
69.23
Others
-1,431.38
72.11
244.84
3.42
34.81
-535.74
-40.44
-3.41
31.90
44.31
Cash from Financing Activity
-532.44
-34.89
-1,091.42
-245.94
-314.16
2.38
-631.12
-302.95
-248.50
-230.76
Net Cash Inflow / Outflow
-815.56
1,987.17
41.05
22.96
-16.60
13.15
0.33
2.54
3.10
-5.33
Opening Cash & Equivalents
2,030.32
43.15
2.10
-20.86
-4.26
-17.41
17.62
15.09
11.99
17.32
Closing Cash & Equivalent
1,214.76
2,030.32
43.15
2.10
-20.86
-4.26
17.95
17.62
15.09
11.99

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
441.82
350.15
275.38
262.09
223.20
201.82
161.73
131.67
111.63
94.20
ROA
22.77%
19.07%
15.11%
15.78%
11.12%
17.21%
22.49%
18.21%
19.92%
19.17%
ROE
28.16%
23.90%
19.30%
21.00%
15.55%
21.98%
28.91%
26.37%
28.31%
25.99%
ROCE
35.06%
32.07%
25.36%
28.50%
21.68%
28.75%
35.57%
33.06%
36.04%
33.21%
Fixed Asset Turnover
1.74
1.70
1.77
1.98
1.88
2.06
1.83
1.70
1.66
1.78
Receivable days
83.26
80.66
86.18
80.35
89.33
79.19
77.83
85.12
88.42
85.08
Inventory Days
100.99
104.66
121.62
115.23
124.56
112.34
113.70
121.69
126.52
127.96
Payable days
95.88
106.32
93.73
52.21
60.15
47.14
35.06
33.55
36.16
42.47
Cash Conversion Cycle
88.36
79.00
114.07
143.37
153.75
144.39
156.47
173.26
178.78
170.58
Total Debt/Equity
0.00
0.00
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
Interest Cover
1842.75
1270.54
255.83
397.38
520.55
416.28
294.75
373.59
336.24
302.96

News Update:


  • Divi's Laboratories reports 26% rise in Q1 consolidated net profit
    12th Aug 2022, 16:53 PM

    Total consolidated income of the company increased by 17.34% at Rs 2342.91 crore for Q1FY23

    Read More
  • Divi’s Laboratories reports 78% rise in Q4 consolidated net profit
    23rd May 2022, 14:38 PM

    The company has reported a standalone net profit of Rs 882.96 crore for the quarter ended March 31, 2022

    Read More
  • Divi's Lab - Quarterly Results
    23rd May 2022, 12:20 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.